Ameritas Investment Partners’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,926
| Closed | -$4.35K | – | 3195 |
|
|
2023
Q1 | $4.35K | Hold |
1,926
| – | – | ﹤0.01% | 2885 |
|
|
2022
Q4 | $8.51K | Hold |
1,926
| – | – | ﹤0.01% | 2846 |
|
|
2022
Q3 | $71K | Hold |
1,926
| – | – | ﹤0.01% | 1732 |
|
|
2022
Q2 | $36K | Hold |
1,926
| – | – | ﹤0.01% | 2209 |
|
|
2022
Q1 | $52K | Buy |
1,926
+684
| +55% | +$18.5K | ﹤0.01% | 2048 |
|
|
2021
Q4 | $28K | Hold |
1,242
| – | – | ﹤0.01% | 2482 |
|
|
2021
Q3 | $33K | Hold |
1,242
| – | – | ﹤0.01% | 2419 |
|
|
2021
Q2 | $40K | Hold |
1,242
| – | – | ﹤0.01% | 2336 |
|
|
2021
Q1 | $44K | Hold |
1,242
| – | – | ﹤0.01% | 2164 |
|
|
2020
Q4 | $40K | Hold |
1,242
| – | – | ﹤0.01% | 2112 |
|
|
2020
Q3 | $47K | Hold |
1,242
| – | – | ﹤0.01% | 1880 |
|
|
2020
Q2 | $56K | Buy |
+1,242
| New | +$56K | ﹤0.01% | 1761 |
|